Home›People›Mark Gossett
MG

Mark Gossett

President and CEO, director at ADVAC Therapeutics.

ExecutiveDirector
Updated Nov 11, 2026·Latest SEC filing Mar 10, 2026·Suggest an edit

About Mark Gossett

Mark Gossett is a president and CEO, director at ADVAC Therapeutics.

Experience

This experience comes from Mark Gossett's profile and from SEC filings. For roles taken from filings, the years are when the filings name Mark Gossett in the role, so the role may have started earlier or lasted longer.

ADVAC Therapeutics Inc Current
President and CEO, director
Founder - CEO (2022 – Present)
2022 – Present · Columus, OH
Onedrus Current
Co-Founder Onedrus LLC
2020 – Present
MCANX LLC Current
Founder CEO
2019 – Present
Truiem
Advisor Life Sciences Solutions
2019 – 2024
Portola Pharmaceuticals
SVP - Commercial/Marketing and VP Strategic InitiativesPlanning
2013 – 2018
vima medical llc
Co-Founder
2010 – 2014
Greenhill Solutions LLC
Founder
2006 – 2013
Relevare Pharmaceuticals
Non- Executive Director
2010 – 2012
Tibotec Therapeutics
Franchise VP - Tibotec Therapeutics
2007 – 2010
ENDO Pharmaceuticals
SVP-Commercial
2004 – 2006
sanofi-aventis
VP Global Marketing - Bone Metabolism / VP US Marketing - Critical Care
1996 – 2004
Wesley-Jessen / Rhone Poulenc Rorer
Other Relevant Experience
1996

Sources

  1. SECADVAC Therapeutics Inc Form D, filed Mar 10, 2026